212 related articles for article (PubMed ID: 28247754)
21. Water-Soluble Combretastatin A4 Phosphate Orally Delivered via Composite Nanoparticles With Improved Inhibition Effect Toward S180 Tumors.
Shen Y; Wu L; Qiu L
J Pharm Sci; 2017 Oct; 106(10):3076-3083. PubMed ID: 28619603
[TBL] [Abstract][Full Text] [Related]
22. Preparation, Optimization, and Evaluation of Methoxy Poly(ethylene glycol)-
Mohamadpour H; Azadi A; Rostamizadeh K; Andalib S; Saghatchi Zanjani MR; Hamidi M
ACS Chem Neurosci; 2020 Mar; 11(5):783-795. PubMed ID: 32043866
[TBL] [Abstract][Full Text] [Related]
23. Enhanced delivery of monomethoxypoly(ethylene glycol)-poly(lactic-co-glycolic acid)-poly l-lysine nanoparticles loading platelet-derived growth factor BB small interfering RNA by ultrasound and/or microbubbles to rat retinal pigment epithelium cells.
Du J; Shi QS; Sun Y; Liu PF; Zhu MJ; Du LF; Duan YR
J Gene Med; 2011 Jun; 13(6):312-23. PubMed ID: 21674734
[TBL] [Abstract][Full Text] [Related]
24. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
Chen J; Li S; Shen Q; He H; Zhang Y
Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
[TBL] [Abstract][Full Text] [Related]
25. Oral Delivery of Puerarin Nanocrystals To Improve Brain Accumulation and Anti-Parkinsonian Efficacy.
Xiong S; Liu W; Li D; Chen X; Liu F; Yuan D; Pan H; Wang Q; Fang S; Chen T
Mol Pharm; 2019 Apr; 16(4):1444-1455. PubMed ID: 30811206
[TBL] [Abstract][Full Text] [Related]
26. [Study on delivery efficiency and cytotoxicity of Hela cells with mPEG-PLGA-BSA-FITC-NPs nanocarrier].
Chen Z; Wu N; Deng X; Wang F; Li K; Guo W; Liu R; Yuan S; Zhang J; Yang S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(1):48-51, 56. PubMed ID: 25966555
[TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of nanoparticles based on mPEG-PLA for controlled delivery of vinpocetine: in vitro and in vivo studies.
Wang R; Xu Y
Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):157-162. PubMed ID: 26838484
[TBL] [Abstract][Full Text] [Related]
28. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
29. [Preparation of cyclosporine A loaded mPEG-PLGA copolymer micelles and study its pharmacokinetics in rats].
Yao DG; Sun KX; Mu HJ; Zhou FM; Chen HH; Liu LJ; Liang N
Yao Xue Xue Bao; 2009 Dec; 44(12):1410-5. PubMed ID: 21351479
[TBL] [Abstract][Full Text] [Related]
30. Alendronate modified mPEG-PLGA nano-micelle drug delivery system loaded with astragaloside has anti-osteoporotic effect in rats.
Xi Y; Wang W; Ma L; Xu N; Shi C; Xu G; He H; Pan W
Drug Deliv; 2022 Dec; 29(1):2386-2402. PubMed ID: 35869674
[TBL] [Abstract][Full Text] [Related]
31. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel.
Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A
J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053
[TBL] [Abstract][Full Text] [Related]
32. Optimization and Characterization of Low-Molecular-Weight Chitosan-Coated Baicalin mPEG-PLGA Nanoparticles for the Treatment of Cataract.
Li N; Zhao Z; Ma H; Liu Y; Nwafor EO; Zhu S; Jia L; Pang X; Han Z; Tian B; Pan H; Liu Z; Pan W
Mol Pharm; 2022 Nov; 19(11):3831-3845. PubMed ID: 36067066
[TBL] [Abstract][Full Text] [Related]
33. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
[TBL] [Abstract][Full Text] [Related]
34. Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.
O'Donnell A; Moollan A; Baneham S; Ozgul M; Pabari RM; Cox D; Kirby BP; Ramtoola Z
J Pharm Pharmacol; 2015 Apr; 67(4):525-36. PubMed ID: 25515568
[TBL] [Abstract][Full Text] [Related]
35. Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.
Rawat P; Manglani K; Gupta S; Kalam A; Vohora D; Ahmad FJ; Talegaonkar S
Pharm Res; 2015 Oct; 32(10):3149-58. PubMed ID: 25840949
[TBL] [Abstract][Full Text] [Related]
36. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats.
Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X
J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669
[TBL] [Abstract][Full Text] [Related]
37. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
38. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil.
Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y
J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486
[TBL] [Abstract][Full Text] [Related]
39. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
40. Inducing angiogenesis with the controlled release of nitric oxide from biodegradable and biocompatible copolymeric nanoparticles.
Yang C; Hwang HH; Jeong S; Seo D; Jeong Y; Lee DY; Lee K
Int J Nanomedicine; 2018; 13():6517-6530. PubMed ID: 30410336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
